152 related articles for article (PubMed ID: 9510057)
1. Neuropeptide Y (NPY) Y1 receptor mRNA is upregulated in association with transient hyperphagia and body weight gain: evidence for a hypothalamic site for concurrent development of leptin resistance.
Kalra PS; Dube MG; Xu B; Farmerie WG; Kalra SP
J Neuroendocrinol; 1998 Jan; 10(1):43-9. PubMed ID: 9510057
[TBL] [Abstract][Full Text] [Related]
2. Increased receptor sensitivity to neuropeptide Y in the hypothalamus may underlie transient hyperphagia and body weight gain.
Kalra PS; Dube MG; Xu B; Kalra SP
Regul Pept; 1997 Oct; 72(2-3):121-30. PubMed ID: 9652971
[TBL] [Abstract][Full Text] [Related]
3. Evidence that dark-phase hyperphagia induced by neurotoxin 6-hydroxydopamine may be due to decreased leptin and increased neuropeptide Y signaling.
Kalra PS; Dube MG; Xu B; Farmerie WG; Kalra SP
Physiol Behav; 1998 Mar; 63(5):829-35. PubMed ID: 9618006
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptide Y release in the paraventricular nucleus is decreased during transient hyperphagia induced by microinjection of colchicine into the ventromedial nucleus of rats.
Jain MR; Dube MG; Kalra SP; Kalra PS
Neurosci Lett; 1998 Oct; 256(1):21-4. PubMed ID: 9832207
[TBL] [Abstract][Full Text] [Related]
5. Hypothalamic galanin is up-regulated during hyperphagia and increased body weight gain induced by disruption of signaling in the ventromedial nucleus.
Dube MG; Kalra SP; Kalra PS
Peptides; 2000 Apr; 21(4):519-26. PubMed ID: 10822107
[TBL] [Abstract][Full Text] [Related]
6. Anorectic effects of the cytokine, ciliary neurotropic factor, are mediated by hypothalamic neuropeptide Y: comparison with leptin.
Xu B; Dube MG; Kalra PS; Farmerie WG; Kaibara A; Moldawer LL; Martin D; Kalra SP
Endocrinology; 1998 Feb; 139(2):466-73. PubMed ID: 9449612
[TBL] [Abstract][Full Text] [Related]
7. Interactions between leptin and hypothalamic neuropeptide Y neurons in the control of food intake and energy homeostasis in the rat.
Wang Q; Bing C; Al-Barazanji K; Mossakowaska DE; Wang XM; McBay DL; Neville WA; Taddayon M; Pickavance L; Dryden S; Thomas ME; McHale MT; Gloyer IS; Wilson S; Buckingham R; Arch JR; Trayhurn P; Williams G
Diabetes; 1997 Mar; 46(3):335-41. PubMed ID: 9032086
[TBL] [Abstract][Full Text] [Related]
8. Melanocortin signaling is decreased during neurotoxin-induced transient hyperphagia and increased body-weight gain.
Dube MG; Pu S; Kalra SP; Kalra PS
Peptides; 2000 Jun; 21(6):793-801. PubMed ID: 10958999
[TBL] [Abstract][Full Text] [Related]
9. Hypothalamic neuropeptide Y/Y1 receptor pathway activated by a reduction in circulating leptin, but not by an increase in circulating ghrelin, contributes to hyperphagia associated with triiodothyronine-induced thyrotoxicosis.
Ishii S; Kamegai J; Tamura H; Shimizu T; Sugihara H; Oikawa S
Neuroendocrinology; 2003 Dec; 78(6):321-30. PubMed ID: 14688445
[TBL] [Abstract][Full Text] [Related]
10. NPY-induced overfeeding suppresses hypothalamic NPY mRNA expression: potential roles of plasma insulin and leptin.
McMinn JE; Seeley RJ; Wilkinson CW; Havel PJ; Woods SC; Schwartz MW
Regul Pept; 1998 Sep; 75-76():425-31. PubMed ID: 9802439
[TBL] [Abstract][Full Text] [Related]
11. Neuropeptide Y1 and Y5 receptors mediate the effects of neuropeptide Y on the hypothalamic-pituitary-thyroid axis.
Fekete C; Sarkar S; Rand WM; Harney JW; Emerson CH; Bianco AC; Beck-Sickinger A; Lechan RM
Endocrinology; 2002 Dec; 143(12):4513-9. PubMed ID: 12446577
[TBL] [Abstract][Full Text] [Related]
12. Disruption of neural signaling within the hypothalamic ventromedial nucleus upregulates galanin gene expression in association with hyperphagia: an in situ hybridization analysis.
Pu S; Dube MG; Edwards TG; Kalra SP; Kalra PS
Brain Res Mol Brain Res; 1999 Jan; 64(1):85-91. PubMed ID: 9889330
[TBL] [Abstract][Full Text] [Related]
13. Disruption in neuropeptide Y and leptin signaling in obese ventromedial hypothalamic-lesioned rats.
Dube MG; Xu B; Kalra PS; Sninsky CA; Kalra SP
Brain Res; 1999 Jan; 816(1):38-46. PubMed ID: 9878684
[TBL] [Abstract][Full Text] [Related]
14. Resistance to the satiety action of leptin following chronic central leptin infusion is associated with the development of leptin resistance in neuropeptide Y neurones.
Sahu A
J Neuroendocrinol; 2002 Oct; 14(10):796-804. PubMed ID: 12372004
[TBL] [Abstract][Full Text] [Related]
15. Hyperphagia and central mechanisms for leptin resistance during pregnancy.
Trujillo ML; Spuch C; Carro E; Señarís R
Endocrinology; 2011 Apr; 152(4):1355-65. PubMed ID: 21303957
[TBL] [Abstract][Full Text] [Related]
16. Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway.
Shintani M; Ogawa Y; Ebihara K; Aizawa-Abe M; Miyanaga F; Takaya K; Hayashi T; Inoue G; Hosoda K; Kojima M; Kangawa K; Nakao K
Diabetes; 2001 Feb; 50(2):227-32. PubMed ID: 11272130
[TBL] [Abstract][Full Text] [Related]
17. Neuropeptide Y counteracts the anorectic and weight reducing effects of ciliary neurotropic factor.
Pu S; Dhillon H; Moldawer LL; Kalra PS; Kalra SP
J Neuroendocrinol; 2000 Sep; 12(9):827-32. PubMed ID: 10971807
[TBL] [Abstract][Full Text] [Related]
18. Young adult-specific hyperphagia in diabetic Goto-kakizaki rats is associated with leptin resistance and elevation of neuropeptide Y mRNA in the arcuate nucleus.
Maekawa F; Fujiwara K; Kohno D; Kuramochi M; Kurita H; Yada T
J Neuroendocrinol; 2006 Oct; 18(10):748-56. PubMed ID: 16965293
[TBL] [Abstract][Full Text] [Related]
19. Daily changes in hypothalamic gene expression of neuropeptide Y, galanin, proopiomelanocortin, and adipocyte leptin gene expression and secretion: effects of food restriction.
Xu B; Kalra PS; Farmerie WG; Kalra SP
Endocrinology; 1999 Jun; 140(6):2868-75. PubMed ID: 10342879
[TBL] [Abstract][Full Text] [Related]
20. The melanocortin agonist Melanotan-II reduces the orexigenic and adipogenic effects of neuropeptide Y (NPY) but does not affect the NPY-driven suppressive effects on the gonadotropic and somatotropic axes in the male rat.
Raposinho PD; White RB; Aubert ML
J Neuroendocrinol; 2003 Feb; 15(2):173-81. PubMed ID: 12535159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
